Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 3Phase 3 2Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 4Terminated 3Recruiting 3Withdrawn 1Unknown 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colonic Neoplasms 2Postoperative Hemorrhage 1Colorectal Neoplasms 1

Interventions

pembrolizumab 219Carboplatin 218Specimen Handling 198Cisplatin 188Magnetic Resonance Spectroscopy 168Radiotherapy 152Bevacizumab 142Gemcitabine 135Cyclophosphamide 133Drug Therapy 118Capecitabine 118Paclitaxel 112Oxaliplatin 110Biopsy 107venetoclax 102Nivolumab 101Rituximab 83tislelizumab 81durvalumab 81toripalimab 77Fluorouracil 73Etoposide 72Dexamethasone 70sintilimab 67Radiosurgery 67Docetaxel 67Pemetrexed 65atezolizumab 64Azacitidine 63Injections 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Lidocaine × Clear all
NCT07432399 2026-03-06

PILDI

Institute of Oncology Ljubljana

Phase 2 Recruiting
100 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT06923787 2026-02-05

PILDI

Institute of Oncology Ljubljana

Phase 2 Recruiting
100 enrolled
Gastrointestinal

Colonic Neoplasms

NCT06057675 2025-08-19

Tranexamic Acid in Nasal Mohs Reconstruction

Vanderbilt University Medical Center

Phase 2 Recruiting
100 enrolled

Postoperative Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡